Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia

The complement activation product Bb in early pregnancy is a biomarker for elevated risk of preeclampsia. This observation suggests that events linked to activation of complement in early pregnancy are associated with the pathogenesis of preeclampsia.